+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Pharmaceutical Drug Delivery Market 2022-2032

  • ID: 5568402
  • Report
  • April 2022
  • Region: Global
  • 321 Pages
  • Future Market Insights
This recent market study on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important market dynamics.

After conducting thorough research on the historical and current growth parameters of the Pharmaceutical Drug Delivery Market, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

The Pharmaceutical Drug Delivery Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.

By Route of Administration

  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery

By Application

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Other Applications

By Facility of Use

  • Hospitals
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Diagnostic Centers
  • Other Facilities of Use

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Pharmaceutical Drug Delivery Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Pharmaceutical Drug Delivery Market, by Key Countries
4.2. Pharmaceutical Drug Delivery Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Pharmaceutical Drug Delivery Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Pharmaceutical Drug Delivery Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Pharmaceutical Drug Delivery Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Pharmaceutical Drug Delivery Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Pharmaceutical Drug Delivery Market Analysis 2015-2021 and Forecast 2022-2032, By Route of Administration
8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022-2032
8.3.1. Oral Drug Delivery
8.3.1.1. Solid Oral Drugs
8.3.1.1.1. Tablets
8.3.1.1.2. Capsules
8.3.1.1.3. Powders
8.3.1.1.4. Pills
8.3.1.2. Liquid Oral Drugs
8.3.1.2.1. Syrups
8.3.1.2.2. Solutions
8.3.1.3. Semi Solid Oral Drugs
8.3.1.3.1. Gels
8.3.1.3.2. Emulsions
8.3.1.3.3. Elixirs
8.3.2. Injectable Drug Delivery
8.3.2.1. Conventional Injection Devices
8.3.2.1.1. By Material
8.3.2.1.1.1. Glass Syringes
8.3.2.1.1.2. Plastic Syringes
8.3.2.1.2. By Product
8.3.2.1.2.1. Fillable syringes
8.3.2.1.2.2. Prefilled syringes
8.3.2.1.3. By Usability
8.3.2.1.3.1. Reusable syringes
8.3.2.1.3.2. Disposable syringes
8.3.2.2. Self-Injection Devices
8.3.2.2.1. Needle-free Injectors
8.3.2.2.2. Autoinjectors
8.3.2.2.3. Pen Injectors
8.3.2.2.4. Wearable Injectors
8.3.2.3. Other Injector Devices
8.3.3. Topical Drug Delivery
8.3.3.1. Liquid Formulations
8.3.3.1.1. Solutions
8.3.3.1.2. Suspensions
8.3.3.2. Semi Solid Formulations
8.3.3.2.1. Creams
8.3.3.2.2. Gels
8.3.3.2.3. Ointments
8.3.3.2.4. Pastes
8.3.3.2.5. Lotions
8.3.3.3. Solid Formulations
8.3.3.3.1. Suppositories
8.3.3.3.2. Powders
8.3.3.4. Transdermal Products
8.3.3.4.1. Transdermal Patches
8.3.3.4.2. Transdermal Gels
8.3.4. Ocular Drug Delivery
8.3.4.1. Liquid Formulations
8.3.4.1.1. Eye Drops
8.3.4.1.2. Liquid Sprays
8.3.4.2. Semi Solid Formulations
8.3.4.2.1. Gels
8.3.4.2.2. Eye Ointments
8.3.4.3. Ocular Devices
8.3.4.3.1. Drug-coated Contact Lenses
8.3.4.3.2. Ocular Inserts
8.3.5. Pulmonary Drug Delivery
8.3.5.1. Metered-Dose Inhalers
8.3.5.2. Dry Powder Inhalers
8.3.5.3. Nebulizers
8.3.5.3.1. Jet Nebulizers
8.3.5.3.2. Ultrasonic Nebulizers
8.3.5.3.3. Soft Mist Nebulizers
8.3.6. Nasal Drug Delivery
8.3.6.1. Nasal Drops
8.3.6.2. Nasal Sprays
8.3.6.3. Nasal Powders
8.3.6.4. Nasal Gels
8.3.7. Transmucosal Drug Delivery
8.3.7.1. Oral Formulations
8.3.7.1.1. Buccal Drug Delivery
8.3.7.1.2. Sublingual Drug Delivery
8.3.7.2. Other Transmucosal Drug Delivery Technologies
8.3.7.2.1. Rectal Transmucosal Drug Delivery
8.3.7.2.2. Vaginal Transmucosal Drug Delivery
8.3.8. Implantable Drug Delivery
8.3.8.1. Active Implantable Drug Delivery
8.3.8.2. Passive Implantable Drug Delivery
8.4. Market Attractiveness Analysis By Route of Administration
9. Global Pharmaceutical Drug Delivery Market Analysis 2015-2021 and Forecast 2022-2032, By Application
9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Application, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032
9.3.1. Infectious Diseases
9.3.2. Cancer
9.3.3. Cardiovascular Diseases
9.3.4. Diabetes
9.3.5. Respiratory Diseases
9.3.6. Central Nervous System Disorders
9.3.7. Autoimmune Diseases
9.3.8. Other Applications
9.4. Market Attractiveness Analysis By Application
10. Global Pharmaceutical Drug Delivery Market Analysis 2015-2021 and Forecast 2022-2032, By Facility of Use
10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Facility of Use, 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Facility of Use, 2022-2032
10.3.1. Hospitals
10.3.2. Ambulatory Surgery Centers/Clinics
10.3.3. Home Care Settings
10.3.4. Diagnostic Centers
10.3.5. Other Facilities of Use
10.4. Market Attractiveness Analysis By Facility of Use
11. Global Pharmaceutical Drug Delivery Market Analysis 2015-2021 and Forecast 2022-2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Pharmaceutical Drug Delivery Market Analysis 2015-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Route of Administration
12.4.3. By Facility of Use
12.4.4. By Application
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Route of Administration
12.5.3. By Facility of Use
12.5.4. By Application
13. Latin America Pharmaceutical Drug Delivery Market Analysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Route of Administration
13.4.3. By Facility of Use
13.4.4. By Application
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Route of Administration
13.5.3. By Facility of Use
13.5.4. By Application
14. Europe Pharmaceutical Drug Delivery Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. U.K.
14.4.1.4. Italy
14.4.1.5. Benelux
14.4.1.6. Nordic Countries
14.4.1.7. Rest of Europe
14.4.2. By Route of Administration
14.4.3. By Facility of Use
14.4.4. By Application
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Route of Administration
14.5.3. By Facility of Use
14.5.4. By Application
15. Asia Pacific Pharmaceutical Drug Delivery Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By Route of Administration
15.4.3. By Facility of Use
15.4.4. By Application
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Route of Administration
15.5.3. By Facility of Use
15.5.4. By Application
16. Middle East and Africa Pharmaceutical Drug Delivery Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. South Africa
16.4.1.3. Turkey
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Route of Administration
16.4.3. By Facility of Use
16.4.4. By Application
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Route of Administration
16.5.3. By Facility of Use
16.5.4. By Application
17. Key Countries Pharmaceutical Drug Delivery Market Analysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Pharmaceutical Drug Delivery Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.2.2.1. By Route of Administration
17.2.2.2. By Facility of Use
17.2.2.3. By Application
17.3. Canada Pharmaceutical Drug Delivery Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.3.2.1. By Route of Administration
17.3.2.2. By Facility of Use
17.3.2.3. By Application
17.4. Mexico Pharmaceutical Drug Delivery Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.4.2.1. By Route of Administration
17.4.2.2. By Facility of Use
17.4.2.3. By Application
17.5. Brazil Pharmaceutical Drug Delivery Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.5.2.1. By Route of Administration
17.5.2.2. By Facility of Use
17.5.2.3. By Application
17.6. Germany Pharmaceutical Drug Delivery Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.6.2.1. By Route of Administration
17.6.2.2. By Facility of Use
17.6.2.3. By Application
17.7. France Pharmaceutical Drug Delivery Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.7.2.1. By Route of Administration
17.7.2.2. By Facility of Use
17.7.2.3. By Application
17.8. Italy Pharmaceutical Drug Delivery Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.8.2.1. By Route of Administration
17.8.2.2. By Facility of Use
17.8.2.3. By Application
17.9. BENELUX Pharmaceutical Drug Delivery Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.9.2.1. By Route of Administration
17.9.2.2. By Facility of Use
17.9.2.3. By Application
17.10. UK Pharmaceutical Drug Delivery Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.10.2.1. By Route of Administration
17.10.2.2. By Facility of Use
17.10.2.3. By Application
17.11. Nordic Countries Pharmaceutical Drug Delivery Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.11.2.1. By Route of Administration
17.11.2.2. By Facility of Use
17.11.2.3. By Application
17.12. China Pharmaceutical Drug Delivery Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.12.2.1. By Route of Administration
17.12.2.2. By Facility of Use
17.12.2.3. By Application
17.13. Japan Pharmaceutical Drug Delivery Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.13.2.1. By Route of Administration
17.13.2.2. By Facility of Use
17.13.2.3. By Application
17.14. South Korea Pharmaceutical Drug Delivery Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.14.2.1. By Route of Administration
17.14.2.2. By Facility of Use
17.14.2.3. By Application
17.15. GCC Countries Pharmaceutical Drug Delivery Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.15.2.1. By Route of Administration
17.15.2.2. By Facility of Use
17.15.2.3. By Application
17.16. South Africa Pharmaceutical Drug Delivery Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.16.2.1. By Route of Administration
17.16.2.2. By Facility of Use
17.16.2.3. By Application
17.17. Turkey Pharmaceutical Drug Delivery Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.17.2.1. By Route of Administration
17.17.2.2. By Facility of Use
17.17.2.3. By Application
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Johnson & Johnson
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. Novartis International AG
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. F. Hoffmann-La Roche AG
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. Pfizer Inc
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. Becton Dickinson & Company
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. Glaxosmithkline PLC
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. Merck & Co Inc
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. Sanofi
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. Bayer AG
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
19.3.10. 3M
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Sales Footprint
19.3.10.4. Strategy Overview
20. Assumptions and Acronyms Used21. Research Methodology

Companies Mentioned

  • Johnson & Johnson
  • Novartis International AG
  • F. Hoffmann-La Roche AG
  • Pfizer Inc
  • Becton Dickinson & Company
  • GlaxoSmithKline plc
  • Merck & Co Inc
  • Sanofi
  • Bayer AG
  • 3M